                         SEQUENCE LISTING

<110>  THALLAPURANAM, Suresh Kumar
       MCNABB, David S.
       AKKAM, Yazan Hussein
       NGUYEN, Duy Tu
 
<120>  PEPTIDES WITH ANTIFUNGAL ACTIVITY AND METHODS OF USING THE 
       PEPTIDES

<130>  5965-00039

<150>  US 61/789,307
<151>  2013-03-15

<160>  24    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa can be Trp, Phe, or Tyr

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa can be Trp, Phe, or Tyr

<400>  1

Xaa Lys Arg Lys Xaa 
1               5   


<210>  2
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM5

<400>  2

Phe Lys Arg Lys Tyr 
1               5   


<210>  3
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM23

<400>  3

Tyr Lys Arg Lys Phe Phe Lys Arg Lys Tyr 
1               5                   10  


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM29

<400>  4

Tyr Lys Arg Lys Phe Lys Arg Lys Tyr 
1               5                   


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM11

<400>  5

Cys Phe Lys Arg Lys Tyr 
1               5       


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa can be Phe or Tyr

<220>
<221>  misc_feature
<222>  (5)..(6)
<223>  Xaa can be Phe or Tyr

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  Xaa can be Phe or Tyr

<400>  6

Xaa Lys Arg Lys Xaa Xaa Lys Arg Lys Xaa 
1               5                   10  


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa can be Phe or Tyr

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa can be Phe or Tyr

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  Xaa can be Phe or Tyr

<400>  7

Xaa Lys Arg Lys Xaa Lys Arg Lys Xaa 
1               5                   


<210>  8
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: Histatin 5 16-mer

<400>  8

Gly Tyr Lys Arg Lys Phe His Glu Lys His His Ser His Arg Gly Tyr 
1               5                   10                  15      


<210>  9
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: Reverse orientation histatin 5 16-mer

<400>  9

Tyr Gly Arg His Ser His His Lys Glu His Phe Lys Arg Lys Tyr Gly 
1               5                   10                  15      


<210>  10
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM6


<220>
<221>  misc_feature
<222>  (1)..(5)
<223>  D-amino acids

<400>  10

Phe Lys Arg Lys Tyr 
1               5   


<210>  11
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM7

<400>  11

Phe Lys Pro Lys Tyr 
1               5   


<210>  12
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM8

<400>  12

Phe Lys Ser Lys Tyr 
1               5   


<210>  13
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM9

<400>  13

Phe Lys Arg Lys Phe 
1               5   


<210>  14
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM10

<400>  14

Lys Phe Arg Tyr Lys 
1               5   


<210>  15
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM12 part 1

<400>  15

Tyr Lys Arg Lys Phe Cys 
1               5       


<210>  16
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM12 part 2

<400>  16

Cys Phe Lys Arg Lys Tyr 
1               5       


<210>  17
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM12 whole


<220>
<221>  DISULFID
<222>  (6)..(7)
<223>  di-sulfide linkage between the two cysteine residues

<400>  17

Tyr Lys Arg Lys Phe Cys Cys Phe Lys Arg Lys Tyr 
1               5                   10          


<210>  18
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM13

<400>  18

Cys Trp Lys Arg Lys Trp 
1               5       


<210>  19
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM14 part 1

<400>  19

Trp Lys Arg Lys Trp Cys 
1               5       


<210>  20
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM14 part 2

<400>  20

Cys Trp Lys Arg Lys Trp 
1               5       


<210>  21
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM14


<220>
<221>  DISULFID
<222>  (6)..(7)
<223>  di-sulfide linkage between the two cysteine residues

<400>  21

Trp Lys Arg Lys Trp Cys Cys Trp Lys Arg Lys Trp 
1               5                   10          


<210>  22
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM15

<400>  22

Phe Lys Cys Arg Lys Tyr 
1               5       


<210>  23
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide: KM17

<400>  23

Cys Phe Lys Arg Lys Tyr Cys 
1               5           


<210>  24
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  24

Tyr Lys Arg Lys Phe 
1               5   


